What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Surgery
- Visual acuity
Her primary areas of investigation include Ophthalmology, Macular degeneration, Optical coherence tomography, Surgery and Visual acuity.
The concepts of her Ophthalmology study are interwoven with issues in Maculopathy and Age related.
Her study in Macular degeneration is interdisciplinary in nature, drawing from both Eye disease, Prospective cohort study and Fluorescein angiography.
The Optical coherence tomography study combines topics in areas such as Retinal pigment epithelium, Retinal, Fundus and Image quality.
Her Surgery research includes themes of Internal medicine and Cardiology.
She has researched Visual acuity in several fields, including Ranibizumab and Randomized controlled trial.
Her most cited work include:
- Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. (1180 citations)
- Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: The Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial (706 citations)
- Automatic segmentation of seven retinal layers in SDOCT images congruent with expert manual segmentation (493 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Ophthalmology, Optical coherence tomography, Retinal, Macular degeneration and Optics.
The study incorporates disciplines such as Prospective cohort study and Surgery in addition to Ophthalmology.
Her research in Optical coherence tomography tackles topics such as Microscope which are related to areas like Visualization.
Her Retinal research incorporates themes from Retina, Anatomy and Pathology.
Her Macular degeneration study incorporates themes from Eye disease, Optometry and Age related.
Her Visual acuity research includes elements of Pro re nata and Ranibizumab.
She most often published in these fields:
- Ophthalmology (49.44%)
- Optical coherence tomography (37.96%)
- Retinal (29.63%)
What were the highlights of her more recent work (between 2015-2021)?
- Ophthalmology (49.44%)
- Optical coherence tomography (37.96%)
- Retinal (29.63%)
In recent papers she was focusing on the following fields of study:
Cynthia A. Toth mostly deals with Ophthalmology, Optical coherence tomography, Retinal, Macular degeneration and Visual acuity.
In general Ophthalmology, her work in Fluorescein angiography, Choroidal neovascularization and Eye disease is often linked to Retinopathy of prematurity linking many areas of study.
As a part of the same scientific study, Cynthia A. Toth usually deals with the Optical coherence tomography, concentrating on Microscope and frequently concerns with Visualization.
Her Retinal study frequently draws connections between adjacent fields such as Retina.
Her work carried out in the field of Macular degeneration brings together such families of science as Scars, Age related and Atrophy.
Her Visual acuity research is multidisciplinary, incorporating perspectives in Ranibizumab and Clinical trial.
Between 2015 and 2021, her most popular works were:
- Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials. (320 citations)
- Macular morphology and visual acuity in the second year of the comparison of age-related macular degeneration treatments trials (94 citations)
- Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials (88 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Visual acuity
- Ophthalmology
The scientist’s investigation covers issues in Ophthalmology, Optical coherence tomography, Macular degeneration, Visual acuity and Prospective cohort study.
Her Ophthalmology research is multidisciplinary, incorporating elements of Optometry and Retina.
Cynthia A. Toth combines subjects such as Operating microscope, Surgery, Microscope, Tomography and Biomedical engineering with her study of Optical coherence tomography.
Specifically, her work in Macular degeneration is concerned with the study of Choroidal neovascularization.
Her research in Visual acuity intersects with topics in Hazard ratio, Ranibizumab, Atrophy and Clinical trial.
Her Prospective cohort study research incorporates themes from Corneal laceration, Randomized controlled trial, Confidence interval, Drusen and Age-Related Eye Disease Study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
